Metraipolis › archive › dc_a2064a22b280

Nirmatrelvir/ritonavir reduced mortality in severe or critical COVID-19 patients: a multicenter retrospective cohort study — Europe PMC PMID:41797786

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41797786
DOI
10.3389/fmed.2026.1747565
License (as archived)
solo-consultazione
Archived
2026-11-05T14:57:59.873Z
SHA-256 of the archived text
20b4a6dfd1f2d1cafffcc9fe7bbf732cf13d765358ecb5e0102f78f38d23c55b
Stable URL of this page
https://metraipolis.com/documento/dc_a2064a22b280

How to cite

Nirmatrelvir/ritonavir reduced mortality in severe or critical COVID-19 patients: a multicenter retrospective cohort study — Europe PMC PMID:41797786 — Europe PMC (en), https://europepmc.org/article/MED/41797786 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a2064a22b280 (Metraipolis archive dc_a2064a22b280, sha256 20b4a6dfd1f2d1cafffcc9fe7bbf732cf13d765358ecb5e0102f78f38d23c55b)
BibTeX
@misc{dca2064a22b280,
  title = {Nirmatrelvir/ritonavir reduced mortality in severe or critical COVID-19 patients: a multicenter retrospective cohort study — Europe PMC PMID:41797786},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41797786},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a2064a22b280; sha256 20b4a6dfd1f2d1cafffcc9fe7bbf732cf13d765358ecb5e0102f78f38d23c55b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41797786. Agents can read the archived copy with the MCP tool read_document.